Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ya-Ling Han

Showing results (211-220 of 219) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 219 results.
American Heart Journal|February 23, 2021
Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trialZhen Ge, Xiao-Fei Gao, Jing Kan, et al.
European Cardiology|November 24, 2021
2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y1<sub>2</sub> Receptor Antagonists in the Asia-Pacific Region: Special PopulationsJack Wei Chieh Tan, Derek P Chew, Kin Lam Tsui, et al.
JACC. Cardiovascular Interventions|January 16, 2022
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT SubstudyMauro Chiarito, Usman Baber, Davide Cao, et al.
The New England Journal of Medicine|September 27, 2019
Ticagrelor with or without Aspirin in High-Risk Patients after PCIRoxana Mehran, Usman Baber, Samin K Sharma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 9, 2021
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT studyGeorge Dangas, Usman Baber, Samin Sharma, et al.
European Heart Journal|October 21, 2020
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACSUsman Baber, George Dangas, Dominick Joseph Angiolillo, et al.
JAMA Network Open|November 17, 2023
Progression of Gastrointestinal Injury During Antiplatelet Therapy After Percutaneous Coronary Intervention: A Secondary Analysis of the OPT-PEACE Randomized Clinical TrialChen He, Yi Li, Xi Jiang, et al.
American Heart Journal|January 19, 2021
Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, randomized, and multicenter DKCRUSH VIII trialZhen Ge, Jing Kan, Xiao-Fei Gao, et al.
BMJ Open|March 8, 2018
Treatment effects of systematic two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: rationale and design of a prospective, randomised and multicentre DEFINITION II trialJun-Jie Zhang, Xiao-Fei Gao, Ya-Ling Han, et al.
Pageof 22

Showing results (211-220 of 219) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 219 results.
American Heart Journal|February 23, 2021
Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trialZhen Ge, Xiao-Fei Gao, Jing Kan, et al.
European Cardiology|November 24, 2021
2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y1<sub>2</sub> Receptor Antagonists in the Asia-Pacific Region: Special PopulationsJack Wei Chieh Tan, Derek P Chew, Kin Lam Tsui, et al.
JACC. Cardiovascular Interventions|January 16, 2022
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT SubstudyMauro Chiarito, Usman Baber, Davide Cao, et al.
The New England Journal of Medicine|September 27, 2019
Ticagrelor with or without Aspirin in High-Risk Patients after PCIRoxana Mehran, Usman Baber, Samin K Sharma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 9, 2021
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT studyGeorge Dangas, Usman Baber, Samin Sharma, et al.
European Heart Journal|October 21, 2020
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACSUsman Baber, George Dangas, Dominick Joseph Angiolillo, et al.
JAMA Network Open|November 17, 2023
Progression of Gastrointestinal Injury During Antiplatelet Therapy After Percutaneous Coronary Intervention: A Secondary Analysis of the OPT-PEACE Randomized Clinical TrialChen He, Yi Li, Xi Jiang, et al.
American Heart Journal|January 19, 2021
Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, randomized, and multicenter DKCRUSH VIII trialZhen Ge, Jing Kan, Xiao-Fei Gao, et al.
BMJ Open|March 8, 2018
Treatment effects of systematic two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: rationale and design of a prospective, randomised and multicentre DEFINITION II trialJun-Jie Zhang, Xiao-Fei Gao, Ya-Ling Han, et al.
Pageof 22